Peters S, et al. Nivolumab + low-dose ipilimumab versus platinum-doublet chemotherapy as first-line treatment for advanced non–small cell lung cancer: CheckMate-227 part 1 final analysis. ESMO Congress 2019, abstract LBA4.
Is aanpassing van de bestralingsdosis mogelijk op basis van de genomische stralengevoeligheid van de tumor?
sep 2017 | Radiotherapie